This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Oncology  • Colon Cancer  • Oncology, Other  • Surgery  • Surgical Interventions  • Surgical Oncology  • Prognosis/ Outcomes  • Hepatobiliary Surgery  • Gastroenterology  • Gastrointestinal Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Anton J. Bilchik, MD, PhD

Arch Surg. 2008;143(12):1158-1159.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Hepatic resection is the only curative option for patients with hepatic metastases from colorectal cancer (CRC). Five-year survival rates after resection have reached almost 60% in recent series.^1-3 This is largely attributed to more sophisticated preoperative imaging techniques, highly sensitive intraoperative ultrasonographic detection of small metastases, improved surgical techniques, and more effective systemic therapies.^3-4

Improved survival and decreased mortality for patients with hepatic CRC have changed the criteria for resection. In the past, surgical candidates were those with no more than 3 tumors, tumors less than 5 cm in greatest diameter, no bilobar disease, no extrahepatic disease, and tumors that could be removed with at least a 1-cm margin of normal hepatic parenchyma. In the modern era of hepatic surgery, the number of candidates for resection has been raised by innovative techniques to increase residual hepatic reserve (portal vein embolization, 2-stage hepatectomy, and radiofrequency ablation) . . . [Full Text of this Article]

AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?